FDA Clearance Tracker · K232732
Rapid Marijuana (THC) Test Strip 20, Rapid Marijuana (THC) Test Dipcard 20, Rapid Marijuana (THC) Test Strip 50, Rapid Marijuana (THC) Test Dipcard 50
Last checked: Nov 20, 2026Latest source record: Jan 17, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jan 17, 2024
Substantially Equivalent
Time to decision
132 days
Received Sep 7, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K232732
- Device name
- Rapid Marijuana (THC) Test Strip 20, Rapid Marijuana (THC) Test Dipcard 20, Rapid Marijuana (THC) Test Strip 50, Rapid Marijuana (THC) Test Dipcard 50
- Applicant
- Co-Innovation Biotech Co., Ltd.
- Applicant location
- Guangzhou, CN
- Received
- Sep 7, 2023
- Decided
- Jan 17, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Enzyme Immunoassay, Cannabinoids (LDJ)
- Device class
- Class II
- Regulation
- 21 CFR 862.3870
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LDJ. The earliest in FDA's data is K812195, decided Aug 20, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K232732
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Co-Innovation Biotech Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241100 · Decided May 22, 2024 · 30 days after receipt
Device type: Test, Opiates, Over The Counter (NGL) · Laboratory Medicine & Pathology
K231904 · Decided Mar 8, 2024 · 254 days after receipt
Device type: Enzyme Immunoassay, Opiates (DJG) · Laboratory Medicine & Pathology
K213808 · Decided Apr 5, 2022 · 120 days after receipt
Device type: Kit, Test, Pregnancy, Hcg, Over The Counter (LCX) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.